Altshuler Shaham’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.49K Buy
+311
New +$8.13K ﹤0.01% 339
2024
Q2
Sell
-10,315
Closed -$286K 343
2024
Q1
$286K Sell
10,315
-87,921
-89% -$2.44M 0.01% 74
2023
Q4
$2.83M Sell
98,236
-7,179,841
-99% -$217M 0.16% 17
2023
Q3
$241M Buy
7,278,077
+29,832
+0.4% +$1.05M 6.55% 5
2023
Q2
$266M Buy
7,248,245
+2,689,114
+59% +$105M 4.67% 8
2023
Q1
$186M Buy
4,559,131
+4,558,602
+861,740% +$197M 4.07% 11
2022
Q4
$27.1K Sell
529
-10,130
-95% -$486K ﹤0.01% 322
2022
Q3
$471K Buy
10,659
+9,395
+743% +$457K 0.01% 98
2022
Q2
$66K Sell
1,264
-659
-34% -$33.6K ﹤0.01% 202
2022
Q1
$100K Sell
1,923
-92,544
-98% -$4.8M ﹤0.01% 265
2021
Q4
$5.45M Sell
94,467
-308,734
-77% -$15.3M 0.05% 76
2021
Q3
$187M Sell
403,201
-1,636,041
-80% -$72.5M 1.37% 24
2021
Q2
$79.9M Buy
2,039,242
+1,998,587
+4,916% +$77.7M 0.6% 28
2021
Q1
$1.47M Buy
40,655
+30,309
+293% +$1.08M 0.01% 86
2020
Q4
$380K Sell
10,346
-86,517
-89% -$3.17M 0.01% 134
2020
Q3
$3.37M Buy
96,863
+40,948
+73% +$1.44M 0.08% 41
2020
Q2
$1.74M Buy
55,915
+5,859
+12% +$199K 0.05% 45
2020
Q1
$1.55M Buy
50,056
+14,059
+39% +$479K 0.07% 42
2019
Q4
$1.34M Hold
35,997
0.04% 64
2019
Q3
$1.24M Buy
35,997
+1,310
+4% +$47.6K 0.05% 58
2019
Q2
$1.43M Buy
34,687
+6,698
+24% +$266K 0.06% 58
2019
Q1
$1.13M Buy
27,989
+10
+0% +$400 0.05% 83
2018
Q4
$1.16M Sell
27,979
-10,074
-26% -$418K 0.05% 80
2018
Q3
$1.59M Hold
38,053
0.08% 72
2018
Q2
$1.31M Hold
38,053
0.11% 74
2018
Q1
$1.28M Buy
38,053
+15,823
+71% +$544K 0.17% 75
2017
Q4
$764K Buy
+22,230
New +$758K 0.11% 68

Other funds holding PFE

Altshuler Shaham's PFE Position: Q2 2026 in Review

Altshuler Shaham opened a new position in Pfizer (PFE) in Q2 2026: 311 shares worth $7.49K. The stake represents ﹤0.01% of the portfolio and ranks #339 among its holdings. This is a return to the name: Altshuler Shaham previously reported a position in PFE as recently as Q1 2024.

Altshuler Shaham first reported a position in PFE in Q4 2017 and has held it in 27 quarters since. The position peaked at $266M in Q2 2023. 2,429 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Altshuler Shaham held 311 shares of Pfizer worth $7.49K as of Q2 2026.
  • Pfizer was a new Altshuler Shaham position in Q2 2026.
  • Pfizer made up ﹤0.01% of Altshuler Shaham's portfolio in Q2 2026, its #339 holding.
  • Altshuler Shaham first reported a position in Pfizer in Q4 2017 and has held it in 27 quarters since.
  • Altshuler Shaham's Pfizer position peaked at $266M in Q2 2023.
  • 2,429 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Altshuler Shaham's 13F filing for Q2 2026, filed 12 Aug 2026.